Dendreon Corp (NASDAQ:DNDN)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

Recs

0
Player Avatar FesterFumble (49.86) Submitted: 3/2/2013 8:47:32 PM : Outperform Start Price: $5.69 DNDN Score: -10.55

Looks cheap.

Featured Broker Partners


Advertisement